Novartis plans the first human tests next year of a “smart” contact lens it is developing with Google designed to help restore the eye’s natural autofocus.
Reuters Health Information
Aerie Pharmaceuticals and Ramot at Tel Aviv University Enter Research Collaboration
IRVINE, Calif. & TEL AVIV, Israel–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye, and Ramot at Tel Aviv University Ltd., Tel Aviv University’s technology transfer company, today announced a research collaboration and license agreement for a preclinical anti-beta amyloid small molecu
Uncategorized
Micropulse laser trabeculoplasty yields 75% success rate in glaucoma patients
BARCELONA — Micropulse laser trabeculoplasty yielded a success rate of 75% after treatment in patients with primary open angle glaucoma, according to a speaker. “The benefits of MLT [micropulse laser trabeculoplasty] are that [there are] no steroids, there is no scarring, there is no risk of infection, it is repeatable, it is a well-tolerated office procedure that can be performed under topical anesthesia, it has zero downtime, and it does not affect the success rates of future glaucoma surgeries,” Jacky W. Y. Lee, MBBS, MRCSEd, FRSCEd, FCOphthHK, FHKAM, said at (Read more...)
Do Children With Acute Demyelinating Conditions Recover?
Pediatric clinicians often see children with demyelinating conditions for their well-child care. These data will be helpful to guide the inevitable conversations about prognosis. Medscape Pediatrics
Uncategorized
Kilimanjaro Centre for Community Ophthalmology Recognized with International Vision Award for Work Restoring Sight to Millions in Developing World
FALLBROOK, Calif.–(BUSINESS WIRE)–KCCO recognized with international vision award for work restoring sight to millions in developing world; VISION 2020 organization recipient of prestigious Champalimaud Vision Award.
Uncategorized
ESCRS FLACS study update: More postop complications with femto than phaco
BARCELONA — The updated European Society of Cataract and Refractive Surgeons study on femtosecond laser-assisted cataract surgery finds that “femto does not outperform phaco,” according to Peter Barry, MD, who delivered this year’s results.Although the ESCRS FLACS study found the femtosecond procedure to result in significantly better outcomes in terms of postoperative and surgically induced astigmatism, postoperative complications outnumbered those of phaco surgery, leading to a significantly higher percentage of patients with worse visual acuity than before surgery, Barry said at the ESCRS meeting.